Cardiac Amyloidosis Therapy: A Systematic Review

Cardiac Amyloidosis Therapy: A Systematic Review

Heart involvement in Cardiac Amyloidosis (CA) results in a worsening of the prognosis in almost all patients with both light-chain (AL) and transthyretin amyloidosis (ATTR). The mainstream CA is a restrictive cardiomyopathy with hypertrophic phenotype at cardiac imaging that clinically leads to hear...

Full description

Bibliographic Details
Main Authors: Franco Iodice, Marco Di Mauro, Marco Giuseppe Migliaccio, Angela Iannuzzi, Roberta Pacileo, Martina Caiazza, Augusto Esposito
Format: Article
Language:English
Published: MDPI AG 2021-01-01
Series:Cardiogenetics
Subjects:
cardiac amyloidosis
therapies amyloidosis
Online Access:https://www.mdpi.com/2035-8148/11/1/2

Internet

https://www.mdpi.com/2035-8148/11/1/2

Similar Items